These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Purification characteristics of new membranes and their implications for the nephrologist]. Glasson P Ther Umsch; 1982 Jul; 39(7):532-6. PubMed ID: 7123505 [No Abstract] [Full Text] [Related]
4. Separation of plasma from whole blood by membrane filtration in oscillatory flows. Stairmand JW; Bellhouse BJ; Jamal Z; Lewis RW; Urban JP; Entwistle CC Life Support Syst; 1986; 4(3):193-204. PubMed ID: 3784601 [TBL] [Abstract][Full Text] [Related]
5. [The effect of the joint use of plasmapheresis and magnetic treatment of the blood on the indices of blood rheology and hemodynamics in hypertension patients]. Alizade IG; Karaeva NT Vopr Kurortol Fizioter Lech Fiz Kult; 1994; (3):10-2. PubMed ID: 7941464 [TBL] [Abstract][Full Text] [Related]
6. Improvement in plasma protein clearance in a model membrane plasma separator employing sequential haemodilution and ultrafiltration. Fisher AC Life Support Syst; 1985; 3 Suppl 1():359-64. PubMed ID: 3870594 [No Abstract] [Full Text] [Related]
7. New products for blood treatment. Sigdell JE Artif Organs; 1985 May; 9(2):207-8. PubMed ID: 4015459 [No Abstract] [Full Text] [Related]
8. Tandem plasmapheresis and haemodialysis as a safe procedure in 82 patients with immune-mediated disease. Dechmann-Sültemeyer T; Linkeschova R; Lenzen K; Kuril Z; Grabensee B; Voiculescu A Nephrol Dial Transplant; 2009 Jan; 24(1):252-7. PubMed ID: 18682492 [TBL] [Abstract][Full Text] [Related]
9. [Plasmapheresis in the treatment of patients with ischemic heart disease]. Konopleva LF; Karpenko VV; Ena IaM; Shekhter IE Vrach Delo; 1991 Dec; (12):13-8. PubMed ID: 1792761 [No Abstract] [Full Text] [Related]
11. Slow continuous intravenous plasmapheresis (SCIP): clinical applications and hemostability of extracorporeal ultrafiltration. Handley HH; Gorsuch R; Peters H; Cooper TG; Bien RH; Levin NW; Ronco C Contrib Nephrol; 2005; 149():334-342. PubMed ID: 15876857 [TBL] [Abstract][Full Text] [Related]
12. An extensive study of donor plasmapheresis using a membrane method by the special study group of the Japanese Red Cross Society. Ikeda H; Tomono T; Sakai E; Endo N; Yokoyama S; Ogawa M; Shiraki H; Kameko S; Sekiguchi S Prog Clin Biol Res; 1990; 337():503-6. PubMed ID: 2112757 [No Abstract] [Full Text] [Related]
13. International forum: "How should a hospital hemapheresis unit be organized?". Int J Artif Organs; 1982 Mar; 5(2):111-9. PubMed ID: 7095881 [No Abstract] [Full Text] [Related]
14. [The effect of therapeutic plasmapheresis on changes in the rheological properties of the blood in bronchial asthma patients]. Polozhentsev SD; Tulupov AN; Gurevich KIa; Krivozubov EF Ter Arkh; 1991; 63(8):19-21. PubMed ID: 1792610 [TBL] [Abstract][Full Text] [Related]
15. Multiple use of plasmafilters. Lai KN; Lai FM; Lam CW J Clin Apher; 1987; 3(4):235-9. PubMed ID: 3680196 [TBL] [Abstract][Full Text] [Related]
16. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome]. Amamiya Y; Baba M; Hisamitsu J; Ito T; Amaki T Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174 [No Abstract] [Full Text] [Related]